Fieldfisher has advised biotechnology company, Link Biologics, on their co-equity fundraising for their innovative dry eye disease (DED) program in partnership with Théa Open Innovation, assisted...
Fieldfisher has advised biotechnology company, Link Biologics, on their co-equity fundraising for their innovative dry eye disease (DED) program in partnership with Théa Open Innovation, assisted...
You must be a Standard 1 Year member to access this content.